Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Tate

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 5, 2013
Evidence-based approach to harmonised reference intervalsGus Koerbin, Ken Andrew Sikaris, Graham Ross Dallas Jones, et al.
Annals of Clinical Biochemistry|April 26, 2007
Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal diseasePeter E Hickman, Gus Koerbin, Emma Southcott, et al.
British Journal of Haematology|March 7, 2012
A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosisPeter Mollee, Campbell Tiley, Ilona Cunningham, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 16, 2014
ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activityKevin J Fagan, Carel J Pretorius, Leigh U Horsfall, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 5, 2013
Evidence-based approach to harmonised reference intervalsGus Koerbin, Ken Andrew Sikaris, Graham Ross Dallas Jones, et al.
Annals of Clinical Biochemistry|April 26, 2007
Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal diseasePeter E Hickman, Gus Koerbin, Emma Southcott, et al.
British Journal of Haematology|March 7, 2012
A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosisPeter Mollee, Campbell Tiley, Ilona Cunningham, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 16, 2014
ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activityKevin J Fagan, Carel J Pretorius, Leigh U Horsfall, et al.
Pageof 3